Vera Therapeutics (VERA) Current Leases (2022 - 2025)
Vera Therapeutics' (VERA) quarterly Current Leases came in at $549000.0 in Q4 2025, down 62.98% YoY from $1.5 million in Q4 2024, and up 16.07% on a QoQ basis from $473000.0 in Q3 2025.
Vera Therapeutics (VERA) Current Leases (2022 - 2025) Analysis & Trends
Vera Therapeutics (VERA) has 4 years of Current Leases data on file, last reported at $549000.0 in Q4 2025.
- Quarterly Current Leases fell 62.98% year-over-year to $549000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $549000.0 (down 62.98% YoY) and the FY2025 annual result came in at $549000.0, down 62.98% from the prior year.
- Current Leases advanced to $549000.0 in Q4 2025, from $473000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.7 million in Q3 2022 to a low of $473000.0 in Q3 2025.
- A 4-year average of $2.0 million and a median of $2.4 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases climbed 4.5% — and 2025, when it plunged 74.73%.
- Tracing VERA's Current Leases over 4 years: stood at $2.6 million in 2022, then retreated by 7.9% to $2.4 million in 2023, then slumped by 39.12% to $1.5 million in 2024, then slumped by 62.98% to $549000.0 in 2025.
- The last three Current Leases figures came in at $549000.0 (Q4 2025), $473000.0 (Q3 2025), and $855000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 549,000.00 |
| Sep 30, 2025 | 473,000.00 |
| Jun 30, 2025 | 855,000.00 |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 2.56 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 2.65 Mn |
| Sep 30, 2022 | 2.69 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 2.49 Mn |